Some experts are worried the securitization market around student loans could pose a systematic risk to the American economy.
JCPenney is spending $1 billion on store and online upgrades in latest bid to revive its business
The money is going toward remodeling JCPenney stores, upgrading its online shopping site and app, and making its supply network more efficient.
Pro-Ron DeSantis super PAC ends door-knocking in Nevada and Super Tuesday states
Never Back Down officials said they were reinvesting in the first three primary states and criticized what they see as a pro-Trump effort to tilt primary rules in his favor elsewhere.
Tesla reportedly facing DOJ, SEC probes over plans to build Elon Musk a large glass house
Tesla is reportedly facing two new federal probes over possible misuse of company resources by or for the personal benefit of CEO Elon Musk.
September breakouts? These stocks are forming the bullish ‘golden cross’ chart pattern
As August comes to a close, a handful of stocks are on the verge of an upward breakout, according to this chart pattern closely watched by technical analysts.
Trump pleads not guilty to election charges in Georgia, waives arraignment
Former President Donald Trump’s arraignment is scheduled on Sept. 6 at 9:30 a.m. ET in Fulton County Superior Court in Atlanta.
Shopify stock pops after company strikes ‘Buy with Prime’ deal with Amazon
The agreement serves as a detente between the two companies after Shopify initially urged merchants not to use Buy with Prime, citing security risks.
China’s sluggish economic recovery has weighed on key Club stocks. Here’s why we’re holding on
The Club’s China-focused names are poised to ride out the storm, while finding alternate routes to growth.
This pitmaster is keeping his family’s 89-year-old BBQ restaurant alive—it brought in $1.5 million last year
Derrick McCray has been the CEO of his family’s restaurant for almost 30 years. The business brought in $1.5 million last year and is a staple in the community.
Ozempic could be the next target of Medicare drug price negotiations – here’s why
Wall Street analysts expect Ozempic to be selected for price negotiations in 2025 due to the amount of money Medicare Part D already spends on the drug.
- « Previous Page
- 1
- …
- 341
- 342
- 343
- 344
- 345
- …
- 1899
- Next Page »